Trade KRSA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Korsana Biosciences, Inc. (KRSA) is trading at US$33.43, up 2.74% today as of Oct 22, 16:00 EDT. The company has a market capitalisation of US$1.98M. Over the past 52 weeks, KRSA has traded between US$21.00 and US$37.27. On Syfe you can trade KRSA with $0 commission and add it to your watchlist.
| Previous close | US$32.54 |
|---|---|
| Market cap | US$1.98M |
| 52-week range | US$21.00 – US$37.27 |
| Volume | 93.04K |
| Exchange | US |
Korsana Biosciences, Inc.
Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
--Stifel Initiates Korsana Biosciences at Buy With $43 Price Target
Sep 14, 10:16 AM · MT Newswires
--TD Cowen Initiates Korsana Biosciences at Buy
Sep 14, 10:16 AM · MT Newswires
--UBS Initiates Korsana Biosciences at Buy With $55 Price Target
Sep 11, 9:25 AM · MT Newswires
Korsana Biosciences, Inc. (KRSA) stock is trading at US$33.43, +2.74% from the previous close of US$32.54.
The market cap for Korsana Biosciences, Inc. (KRSA) stock is approximately US$1.98M.
The 52-week high for Korsana Biosciences, Inc. (KRSA) stock is US$37.27.
The 52-week low for Korsana Biosciences, Inc. (KRSA) stock is US$21.00.
Korsana Biosciences, Inc. (KRSA) does not currently pay a dividend.
Stay on top of KRSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
